STOCK TITAN

[Form 4/A] Kellanova Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

Calix, Inc. (CALX) filed a Form 144 disclosing a planned sale of 108,000 common shares through Morgan Stanley Smith Barney on or after 07/23/2025. The block is valued at $6.064 million and represents roughly 0.17 % of the 65.30 million shares outstanding. The shares were acquired via a same-day stock-option exercise paid in cash.

The notice also lists prior sales by the same filer in the past three months: 92,000 shares on 07/22/2025 for $5.06 million and 100,000 shares on 06/02/2025 for $4.66 million. Including the current intent, the seller has disposed of or plans to dispose of 300,000 shares—about 0.46 % of outstanding stock—generating total gross proceeds near $15.8 million.

While Form 144 filings do not guarantee execution, they flag affiliate selling activity that investors often watch for signals on insider sentiment.

Calix, Inc. (CALX) ha presentato un modulo Form 144 che annuncia la prevista vendita di 108.000 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 23/07/2025. Il blocco è valutato 6,064 milioni di dollari e rappresenta circa il 0,17% delle 65,30 milioni di azioni in circolazione. Le azioni sono state acquisite tramite l'esercizio di opzioni su azioni nello stesso giorno, pagato in contanti.

La comunicazione elenca anche vendite precedenti effettuate dallo stesso soggetto negli ultimi tre mesi: 92.000 azioni il 22/07/2025 per 5,06 milioni di dollari e 100.000 azioni il 02/06/2025 per 4,66 milioni di dollari. Includendo l'intenzione attuale, il venditore ha ceduto o prevede di cedere 300.000 azioni, pari a circa lo 0,46% del capitale sociale, generando un ricavo lordo totale vicino a 15,8 milioni di dollari.

Pur non garantendo l'esecuzione, le segnalazioni tramite Form 144 indicano attività di vendita da parte di affiliati, che gli investitori spesso osservano per cogliere segnali sul sentiment interno.

Calix, Inc. (CALX) presentó un Formulario 144 que revela una venta planificada de 108,000 acciones ordinarias a través de Morgan Stanley Smith Barney a partir del 23/07/2025. El lote está valorado en 6.064 millones de dólares y representa aproximadamente el 0,17% de las 65,30 millones de acciones en circulación. Las acciones fueron adquiridas mediante el ejercicio de opciones sobre acciones el mismo día, pagado en efectivo.

El aviso también menciona ventas anteriores por el mismo declarante en los últimos tres meses: 92,000 acciones el 22/07/2025 por 5,06 millones de dólares y 100,000 acciones el 02/06/2025 por 4,66 millones de dólares. Incluyendo la intención actual, el vendedor ha vendido o planea vender 300,000 acciones, alrededor del 0,46% del capital en circulación, generando ingresos brutos totales cercanos a 15,8 millones de dólares.

Aunque las presentaciones del Formulario 144 no garantizan la ejecución, señalan actividad de venta por parte de afiliados que los inversores suelen observar para interpretar el sentimiento interno.

Calix, Inc. (CALX)는 2025년 7월 23일 이후 Morgan Stanley Smith Barney를 통해 108,000주의 보통주를 매각할 계획임을 알리는 Form 144를 제출했습니다. 이 매각 블록의 가치는 606만 4천 달러이며, 총 6,530만 주 중 약 0.17%에 해당합니다. 해당 주식은 당일 현금으로 지급된 주식 옵션 행사로 취득되었습니다.

해당 통지서에는 동일 제출자가 최근 3개월 내에 진행한 이전 매각 내역도 포함되어 있습니다: 2025년 7월 22일에 92,000주를 506만 달러에, 2025년 6월 2일에 100,000주를 466만 달러에 매각했습니다. 현재 계획을 포함하면, 판매자는 총 300,000주를 처분했거나 처분할 예정이며, 이는 발행 주식의 약 0.46%에 해당하고 총 총수익은 약 1,580만 달러에 달합니다.

Form 144 제출이 거래 실행을 보장하지는 않지만, 투자자들이 내부자 심리의 신호로 주목하는 계열사 판매 활동을 알리는 역할을 합니다.

Calix, Inc. (CALX) a déposé un formulaire 144 révélant une vente prévue de 108 000 actions ordinaires via Morgan Stanley Smith Barney à partir du 23/07/2025. Le bloc est évalué à 6,064 millions de dollars et représente environ 0,17 % des 65,30 millions d'actions en circulation. Les actions ont été acquises par l'exercice d'options sur actions le jour même, payé en espèces.

L'avis mentionne également des ventes antérieures effectuées par le même déclarant au cours des trois derniers mois : 92 000 actions le 22/07/2025 pour 5,06 millions de dollars et 100 000 actions le 02/06/2025 pour 4,66 millions de dollars. En incluant l'intention actuelle, le vendeur a cédé ou prévoit de céder 300 000 actions, soit environ 0,46 % du capital en circulation, générant un produit brut total proche de 15,8 millions de dollars.

Bien que les dépôts du formulaire 144 ne garantissent pas l'exécution, ils signalent une activité de vente d'affiliés que les investisseurs surveillent souvent pour détecter des indices sur le sentiment des initiés.

Calix, Inc. (CALX) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 108.000 Stammaktien über Morgan Stanley Smith Barney ab dem 23.07.2025 offenlegt. Das Paket wird mit 6,064 Millionen US-Dollar bewertet und entspricht etwa 0,17% der 65,30 Millionen ausstehenden Aktien. Die Aktien wurden durch eine am selben Tag in bar bezahlte Ausübung von Aktienoptionen erworben.

Die Mitteilung listet auch frühere Verkäufe desselben Meldenden in den letzten drei Monaten auf: 92.000 Aktien am 22.07.2025 für 5,06 Millionen US-Dollar und 100.000 Aktien am 02.06.2025 für 4,66 Millionen US-Dollar. Einschließlich der aktuellen Absicht hat der Verkäufer 300.000 Aktien veräußert oder plant dies, was etwa 0,46% des ausstehenden Aktienkapitals entspricht und einen Bruttoerlös von rund 15,8 Millionen US-Dollar generiert.

Obwohl Form 144-Meldungen keine Ausführung garantieren, signalisieren sie Verkaufsaktivitäten von verbundenen Personen, die Investoren oft als Indikator für die Insiderstimmung beobachten.

Positive
  • None.
Negative
  • Affiliate intends to sell 108,000 shares worth $6.064 m, following two recent sales totaling 192,000 shares, signaling sustained insider liquidation.
  • Total 300,000 shares sold/expected in 3 months (~0.46 % of shares outstanding) may create perceived stock-supply overhang and raise questions about insider confidence.

Insights

TL;DR Insider plans third sizable sale in 3 months, totaling 300 k shares (~0.46 % O/S); may pressure sentiment but limited mechanical impact.

The Form 144 adds another 108 k shares to two recent sales worth $9.7 m, bringing intended dispositions to roughly $15.8 m. Although the volume is modest relative to float, clustering of transactions can influence perception of management confidence and near-term stock supply. No dilution occurs because the sale is secondary, yet continued insider monetization after option exercise can act as an overhang, especially ahead of earnings windows.

TL;DR Repeated affiliate selling could raise governance questions on alignment; magnitude remains immaterial to voting power.

Rule 144 filings require insiders to certify absence of undisclosed negative information, but three sales inside one quarter may trigger investor scrutiny around long-term commitment. The 0.46 % stake reduction is unlikely to alter control dynamics; however, boards often monitor clustering patterns to evaluate optics and potential policy adjustments (e.g., 10b5-1 plans). From a governance lens the event is noteworthy yet not structurally harmful.

Calix, Inc. (CALX) ha presentato un modulo Form 144 che annuncia la prevista vendita di 108.000 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 23/07/2025. Il blocco è valutato 6,064 milioni di dollari e rappresenta circa il 0,17% delle 65,30 milioni di azioni in circolazione. Le azioni sono state acquisite tramite l'esercizio di opzioni su azioni nello stesso giorno, pagato in contanti.

La comunicazione elenca anche vendite precedenti effettuate dallo stesso soggetto negli ultimi tre mesi: 92.000 azioni il 22/07/2025 per 5,06 milioni di dollari e 100.000 azioni il 02/06/2025 per 4,66 milioni di dollari. Includendo l'intenzione attuale, il venditore ha ceduto o prevede di cedere 300.000 azioni, pari a circa lo 0,46% del capitale sociale, generando un ricavo lordo totale vicino a 15,8 milioni di dollari.

Pur non garantendo l'esecuzione, le segnalazioni tramite Form 144 indicano attività di vendita da parte di affiliati, che gli investitori spesso osservano per cogliere segnali sul sentiment interno.

Calix, Inc. (CALX) presentó un Formulario 144 que revela una venta planificada de 108,000 acciones ordinarias a través de Morgan Stanley Smith Barney a partir del 23/07/2025. El lote está valorado en 6.064 millones de dólares y representa aproximadamente el 0,17% de las 65,30 millones de acciones en circulación. Las acciones fueron adquiridas mediante el ejercicio de opciones sobre acciones el mismo día, pagado en efectivo.

El aviso también menciona ventas anteriores por el mismo declarante en los últimos tres meses: 92,000 acciones el 22/07/2025 por 5,06 millones de dólares y 100,000 acciones el 02/06/2025 por 4,66 millones de dólares. Incluyendo la intención actual, el vendedor ha vendido o planea vender 300,000 acciones, alrededor del 0,46% del capital en circulación, generando ingresos brutos totales cercanos a 15,8 millones de dólares.

Aunque las presentaciones del Formulario 144 no garantizan la ejecución, señalan actividad de venta por parte de afiliados que los inversores suelen observar para interpretar el sentimiento interno.

Calix, Inc. (CALX)는 2025년 7월 23일 이후 Morgan Stanley Smith Barney를 통해 108,000주의 보통주를 매각할 계획임을 알리는 Form 144를 제출했습니다. 이 매각 블록의 가치는 606만 4천 달러이며, 총 6,530만 주 중 약 0.17%에 해당합니다. 해당 주식은 당일 현금으로 지급된 주식 옵션 행사로 취득되었습니다.

해당 통지서에는 동일 제출자가 최근 3개월 내에 진행한 이전 매각 내역도 포함되어 있습니다: 2025년 7월 22일에 92,000주를 506만 달러에, 2025년 6월 2일에 100,000주를 466만 달러에 매각했습니다. 현재 계획을 포함하면, 판매자는 총 300,000주를 처분했거나 처분할 예정이며, 이는 발행 주식의 약 0.46%에 해당하고 총 총수익은 약 1,580만 달러에 달합니다.

Form 144 제출이 거래 실행을 보장하지는 않지만, 투자자들이 내부자 심리의 신호로 주목하는 계열사 판매 활동을 알리는 역할을 합니다.

Calix, Inc. (CALX) a déposé un formulaire 144 révélant une vente prévue de 108 000 actions ordinaires via Morgan Stanley Smith Barney à partir du 23/07/2025. Le bloc est évalué à 6,064 millions de dollars et représente environ 0,17 % des 65,30 millions d'actions en circulation. Les actions ont été acquises par l'exercice d'options sur actions le jour même, payé en espèces.

L'avis mentionne également des ventes antérieures effectuées par le même déclarant au cours des trois derniers mois : 92 000 actions le 22/07/2025 pour 5,06 millions de dollars et 100 000 actions le 02/06/2025 pour 4,66 millions de dollars. En incluant l'intention actuelle, le vendeur a cédé ou prévoit de céder 300 000 actions, soit environ 0,46 % du capital en circulation, générant un produit brut total proche de 15,8 millions de dollars.

Bien que les dépôts du formulaire 144 ne garantissent pas l'exécution, ils signalent une activité de vente d'affiliés que les investisseurs surveillent souvent pour détecter des indices sur le sentiment des initiés.

Calix, Inc. (CALX) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 108.000 Stammaktien über Morgan Stanley Smith Barney ab dem 23.07.2025 offenlegt. Das Paket wird mit 6,064 Millionen US-Dollar bewertet und entspricht etwa 0,17% der 65,30 Millionen ausstehenden Aktien. Die Aktien wurden durch eine am selben Tag in bar bezahlte Ausübung von Aktienoptionen erworben.

Die Mitteilung listet auch frühere Verkäufe desselben Meldenden in den letzten drei Monaten auf: 92.000 Aktien am 22.07.2025 für 5,06 Millionen US-Dollar und 100.000 Aktien am 02.06.2025 für 4,66 Millionen US-Dollar. Einschließlich der aktuellen Absicht hat der Verkäufer 300.000 Aktien veräußert oder plant dies, was etwa 0,46% des ausstehenden Aktienkapitals entspricht und einen Bruttoerlös von rund 15,8 Millionen US-Dollar generiert.

Obwohl Form 144-Meldungen keine Ausführung garantieren, signalisieren sie Verkaufsaktivitäten von verbundenen Personen, die Investoren oft als Indikator für die Insiderstimmung beobachten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST

(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KELLANOVA [ K ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
07/21/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/21/2025 07/21/2025 S 114,583(1) D $79.8697(2) 45,670,369 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST

(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION

(Last) (First) (Middle)
ONE MICHIGAN AVENUE EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. 45,670,369 shares were owned following the reported transaction by the W.K. Kellogg Foundation Trust (the "Trust") of which LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company are Trustees and the W.K. Kellogg Foundation (the "Foundation") is the sole beneficiary.
2. This Form 4/A is being filed to amend the original Form 4 filed on July 21, 2025, to correct an administrative error. The original filing reported an average price of $79.92 for the sale transaction that occurred on July 21, 2025. The correct average price is $79.8697.
Remarks:
The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.
Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, as Corporate Trustee of the W.K. Kellogg Foundation Trust and signing for the W.K. Kellogg Foundation pursuant to a Power of Attorney dated August 30, 2017 07/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CALX file on Form 144?

A notice of intent to sell 108,000 common shares under Rule 144.

How much are the shares worth?

The aggregate market value is approximately $6.064 million.

When is the planned sale date for CALX shares?

The filing lists an approximate sale date of 07/23/2025 on the NYSE.

How many CALX shares has the seller disposed of recently?

Including this notice, the filer has sold or plans to sell 300,000 shares over the last three months.

Does a Form 144 guarantee the shares will be sold?

No. It only signals the affiliate’s intent; the transaction may or may not occur.
Kellanova

NYSE:K

K Rankings

K Latest News

K Latest SEC Filings

K Stock Data

27.79B
344.99M
0.96%
82.32%
1.91%
Packaged Foods
Grain Mill Products
Link
United States
CHICAGO